(Q38001330)

26 August 2017

title

Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy (English)

1 reference

26 August 2017

1 reference

Shuji Terai

1

1 reference

26 August 2017

Haruko Tanimoto

2

1 reference

26 August 2017

Masaki Maeda

3

1 reference

26 August 2017

Junichi Zaitsu

4

1 reference

26 August 2017

Takuro Hisanaga

5

1 reference

26 August 2017

Takuya Iwamoto

6

1 reference

26 August 2017

Koichi Fujisawa

7

1 reference

26 August 2017

Yuko Mizunaga

8

1 reference

26 August 2017

Toshihiko Matsumoto

9

1 reference

26 August 2017

Yohei Urata

10

1 reference

26 August 2017

Yoshio Marumoto

11

1 reference

26 August 2017

Isao Hidaka

12

1 reference

26 August 2017

Tsuyoshi Ishikawa

13

1 reference

26 August 2017

Yuichiro Yokoyama

14

1 reference

26 August 2017

Koji Aoyama

15

1 reference

26 August 2017

Masako Tsuchiya

16

1 reference

26 August 2017

Taro Takami

17

1 reference

26 August 2017

Kaoru Omori

18

1 reference

26 August 2017

Naoki Yamamoto

19

1 reference

26 August 2017

Makoto Segawa

20

1 reference

26 August 2017

Koichi Uchida

21

1 reference

26 August 2017

Takahiro Yamasaki

22

1 reference

26 August 2017

Kiwamu Okita

23

1 reference

26 August 2017

Isao Sakaida

24

1 reference

26 August 2017

publication date

5 April 2012

1 reference

Journal of Gastroenterology

26 August 2017

published in

1 reference

26 August 2017

volume

47

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

491-497

1 reference

Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

An In Vivo Model for Monitoring Trans-Differentiation of Bone Marrow Cells into Functional Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Lesson from the GFP/CCl4 model--translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0580-5

Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes

21 January 2018

1 reference

12 December 2020

Bone marrow stem cells and liver disease

1 reference

12 December 2020

Characterization and Clinical Application of Human CD34+Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony-Stimulating Factor

1 reference

12 December 2020

Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis

1 reference

12 December 2020

Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients.

1 reference

12 December 2020

Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial

1 reference

12 December 2020

Granulocyte colony-stimulating factor and interleukin-1β are important cytokines in repair of the cirrhotic liver after bone marrow cell infusion: comparison of humans and model mice

1 reference

12 December 2020

Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4.

1 reference

12 December 2020

Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.

1 reference

12 December 2020

Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice

1 reference

12 December 2020

10.1007/S00535-012-0580-5

Identifiers

DOI

1 reference

26 August 2017

1 reference